PIK3CA and breast cancer: Therefore, in the present study we for the first time performed a case-control study to explore systematically the correlation of PI3K/PTEN/AKT pathway genetic variations with the susceptibility, clinicopathological features, and response to treatment and clinical outcomes of BC patients after CE(A)F regimen.